Abstract
The molecular marker, cardiac troponin (cTn) is a complex protein that is attached to tropomyosin on the actin filament. It is an essential biomolecule in terms of the calcium-mediated regulation of the contractile apparatus in myofibrils, the release of which is an indication of the dysfunction of cardiomyocytes and hence the initiation of ischemic phenomena in the heart tissue. Fast and accurate analysis of cTn may help the diagnosis and management of acute myocardial infarction (AMI), for which electrochemical biosensors and microfluidics devices can be of great benefit. This editorial aims to highlight the importance of cTn as vital biomarkers in AMI diagnosis.
| Original language | English |
|---|---|
| Pages (from-to) | 85-88 |
| Number of pages | 4 |
| Journal | BioImpacts |
| Volume | 13 |
| Issue number | 2 |
| DOIs | |
| State | Published - Mar 2023 |
Bibliographical note
Publisher Copyright:© 2023 The Author(s). This work is published by BioImpacts as an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/). Non-commercial uses of the work are permitted, provided the original work is properly cited.
ASJC Scopus Subject Areas
- General Biochemistry,Genetics and Molecular Biology
- Pharmaceutical Science
Keywords
- Acute myocardial infarction
- Biosensor
- Cardiac troponin
- Cardiomyocytes
- Electrochemical analysis
- Microfluidics
Disciplines
- Biochemistry
- Pharmacy and Pharmaceutical Sciences
Fingerprint
Dive into the research topics of 'Diagnosis of acute myocardial infarction: highlighting cardiac troponins as vital biomarkers'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS